Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10053111HBVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS10041111HBVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS30008344HIVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS30057445HIVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS30057446HIVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS30057447HIVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS20016701HPVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TVIS20016702HPVENSG00000010322.16protein_codingNISCHNoNo11188Q9Y2I1
TCGA Plot Options
Drug Information
GeneNISCH
DrugBank IDDB00697
Drug NameTizanidine
Target IDBE0003580
UniProt IDQ9Y2I1
Regulation Typeagonist
PubMed IDs18602099; 26962521
CitationsTanabe M, Hashimoto M, Ono H: Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease. Eur J Pharmacol. 2008 Jul 28;589(1-3):102-5. doi: 10.1016/j.ejphar.2008.06.013. Epub 2008 Jun 7.@@Talakoub R, Abbasi S, Maghami E, Zavareh SM: The effect of oral tizanidine on postoperative pain relief after elective laparoscopic cholecystectomy. Adv Biomed Res. 2016 Feb 8;5:19. doi: 10.4103/2277-9175.175905. eCollection 2016.
GroupsApproved; Investigational
Direct ClassificationBenzothiadiazoles
SMILESClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Pathways
PharmGKBPA451701
ChEMBLCHEMBL1079